<DOC>
	<DOCNO>NCT01299350</DOCNO>
	<brief_summary>Our objective compare policy hospital discharge guide NT-proBNP level versus discharge guide conventional clinical criterion , patient admit acute heart failure . The hypothesis Nt-proBNP guide discharge shorten hospital stay without worsen outcome</brief_summary>
	<brief_title>Nt-proBNP Versus Clinical Guided Discharge Acute Heart Failure</brief_title>
	<detailed_description>Nt-proBNP level well response pharmacological treatment predictive prognosis patient heart failure . The purpose present project investigate , patient hospitalize acute heart failure , whether discharge decision guide Nt-proBNP response shorten hospital stay improve prognosis The included patient randomly assign one two strategy : hospital discharge accord clinical conventional criterion discharge guide Nt-proBNP . All patient treat follow clinical guideline . In guided Nt-proBNP strategy , patient discharge third day NT-proBNP level drop &gt; 30 % compare admission value . If reduction achieve , pharmacological treatment increase NT-proBNP measure following day reach 30 % reduction . In conventional strategy , patient discharge criterion attend cardiologist accord clinical assessment without Nt-proBNP . The main outcome number day hospitalization index episode , secondary outcome death readmission heart failure one 6 month . Our hypothesis Nt-proBNP guide discharge allow precisely evaluate response treatment determine best time hospital discharge . This reduce hospital stay death readmission rate discharge .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1. clinical sign symptom acute heart failure , accord criterion European guideline 2 . NTproBNP level &gt; 1000 pg/ml time admission 3. age 18 year old 4. sign inform consent 1 . GFR le 30 ml/minute/m2 , 2. life expectancy determine concomitant disease one year , 3. acute coronary syndrome within 10 day prior , 4. valvular heart disease surgical approach , 5. infection process active malignancy , 6. chronic respiratory failure pulmonary disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Nt-proBNP</keyword>
</DOC>